Blog
RSS FeedPosted by Michael Wonder on 09 Feb 2020
Extreme regulations to lower drug prices mean Canada will get fewer new drugs
7 February 2020 - Severe price cuts would clearly discourage pharmaceutical manufacturers from launching new drugs in Canada. ...
Posted by Michael Wonder on 05 Feb 2020
Pharma execs argue new Canadian regulations for setting drug prices will hurt the country
4 February 2020 - As Canada gets set to implement new regulations designed to cut prescription drug spending, the pharmaceutical ...
Posted by Michael Wonder on 02 Dec 2019
Premiers want Ottawa to allow opt out for proposed Pharmacare plan
2 December 2019 - Canada's premiers say they want the federal government to increase health-care transfer funds by just over ...
Posted by Michael Wonder on 25 Nov 2019
Proposed Ontario drug regulation changes worry policy experts
22 November 2019 - The Ontario government is proposing drug regulation changes that it says will remove red tape and ...
Posted by Michael Wonder on 24 Sep 2019
Institutional investors urging Congress to vote down CUSMA, citing effect on drug prices
23 September 2019 - A group of institutional investors representing more than US$500 billion is calling on the U.S. Congress ...
Posted by Michael Wonder on 10 Sep 2019
Canada releases final amendments to patented medicines pricing regulations
9 September 2019 - On 9 August 2019 Health Canada announced the final amendments to the Patented Medicines Regulations. ...
Posted by Michael Wonder on 08 Sep 2019
Trudeau’s drug price overhaul is set to cost drug makers billions
6 September 2019 - Canada revamps drug-pricing regime for first time since 1987. ...
Posted by Michael Wonder on 26 Aug 2019
Drug-price reforms need not affect research on rare diseases – or the Canadians who have them
26 August 2019 - On 9 August, the Patented Medicine Prices Review Board of Canada announced new drug-pricing regulations for ...
Posted by Michael Wonder on 24 Aug 2019
Companies file suit in Canada challenging new rules to lower drug prices
23 August 2019 - Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging ...
Posted by Michael Wonder on 21 Aug 2019
Empirical evidence supports critics of Patented Medicine Prices Review Board regulations
21 August 2019 - Canadian Health Policy Institute, a Toronto-based private-sector think-tank established in 2012, has published several studies that bolster ...
Posted by Michael Wonder on 18 Aug 2019
Bring in pharmacare now, health experts ask federal leaders
15 August 2019 - Signatories include professors of medicine, pharmacy, nursing, economics, political science and law. ...
Posted by Michael Wonder on 16 Aug 2019
What will PMPRB drug pricing changes mean for plan sponsors?
15 August 2019 - Private plan sponsors can expect to see lower drug prices resulting from recent changes to the ...
Posted by Michael Wonder on 14 Aug 2019
Canadians benefitting from substantially lower generic drug prices
14 August 2019 - Latest agreement between public payers and the Canadian generic industry closes gap with international prices. ...
Posted by Michael Wonder on 13 Aug 2019
Ottawa’s move to cut drug prices may lead to fewer new launches, less R&D
13 August 2019 - Health Canada is fundamentally changing how prescription drugs are priced in Canada. ...
Posted by Michael Wonder on 13 Aug 2019
Proposed new drug regulations will hurt all Canadians — and Ottawa has been warned
13 August 2019 - Changes which aim to make prescriptions more affordable could shut off entry of new drugs. ...